Sunesis Announces Clinical Trial Updates and 2013 Milestones at the 31st Annual JP Morgan Healthcare Conference

[at noodls] – VALOR Enrollment Reaches 500 Patients; Enrollment Doubles in LI-1 Trial SOUTH SAN FRANCISCO, Calif., Jan. 10, 2013 (GLOBE NEWSWIRE) — Sunesis Pharmaceuticals, Inc. (Nasdaq:SNSS) today announced that Daniel … more

View todays social media effects on SNSS

View the latest stocks trending across Twitter. Click to view dashboard

See who Sunesis is hiring next, click here to view